Research Article
Metabolic Syndrome in People Living with Human Immunodeficiency Virus: An Assessment of the Prevalence and the Agreement between Diagnostic Criteria
Table 2
Characteristics of the HIV-infected participants.
| | Characteristics | Total | Men | Women | value | | Median (25th–75th percentiles) | | | |
| | Age (years) | 38 (32–44) | 41 (35–47) | 37 (31–43) | <0.001 | | Anthropometry | | | | | | Body mass index (kg/m2) | 26.3 (22.1–32) | 21.4 (19.8–22.4) | 28.3 (23.8–28.9) | <0.001 | | Waist circumference (cm) | 88 (78–98) | 79 (74–88) | 90 (80–101) | <0.001 | | Waist-to-hip ratio | 0.86 (0.8–0.91) | 0.87 (0.84–0.93) | 0.85 (0.8–0.9) | <0.001 |
| | Blood pressure (mmHg) | | Systolic | 117 (107–130) | 123.5 (114.5–140) | 115 (105.8–127) | <0.001 | | Diastolic | 82 (75–91) | 83 (76–94) | 81.5 (74.8–89.8) | 0.129 |
| | Lipid variables (mmol/L) | | Total cholesterol | 4.3 (3.7–5.1) | 4.2 (3.5–3.8) | 4.4 (3.8–5.1) | 0.009 | | LDL-C | 2.5 (2.0–3.1) | 2.3 (1.7–3.0) | 2.5 (2.0–3.1) | 0.012 | | HDL-C | 1.3 (1–1.5) | 1.2 (1.0–1.5) | 1.29 (1.08–1.52) | 0.010 | | Triglycerides | 1 (0.7–1.3) | 1.12 (0.75–1.27) | 0.97 (0.74–1.28) | 0.023 | | Fasting glucose (mmol/L) | 5 (4.6–5.4) | 5.1 (4.8–5.5) | 4.9 (4.6–5.4) | 0.010 | | HOMA-IR | 1.36 (0.84–2.24) | 0.94 (0.53–1.64) | 1.49 (0.93–2.37) | <0.001 |
| | HIV-related factors | | HIV duration (years) | 5 (2–9) | 4 (2–7) | 5 (2.5–9) | <0.001 | | CD4 count (cells/mm3) | 392 (240–604) | 272 (193–448) | 410 (253–627) | 0.001 |
| | Number (%) | | | | | | Antiretroviral treatment | | | | 0.005 | | None | 46 (6.6) | 7 (4.7) | 39 (7.1) | | | 1st line | 426 (60.9) | 78 (52.3) | 348 (63.3) | | | 2nd line | 79 (11.3) | 17 (11.4) | 62 (11.3) | | | Others | 148 (21.2) | 47 (31.5) | 101 (18.3) | |
|
|
LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HIV: human immunodeficiency virus; HOMA index: homeostatic model assessment of insulin resistance.
|
